Aldebaran Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,250
| Closed | -$293K | – | 85 |
|
2022
Q1 | $293K | Sell |
2,250
-200
| -8% | -$26K | 0.23% | 73 |
|
2021
Q4 | $374K | Hold |
2,450
| – | – | 0.28% | 64 |
|
2021
Q3 | $396K | Hold |
2,450
| – | – | 0.32% | 58 |
|
2021
Q2 | $402K | Hold |
2,450
| – | – | 0.33% | 57 |
|
2021
Q1 | $369K | Hold |
2,450
| – | – | 0.33% | 61 |
|
2020
Q4 | $371K | Hold |
2,450
| – | – | 0.35% | 57 |
|
2020
Q3 | $332K | Hold |
2,450
| – | – | 0.35% | 57 |
|
2020
Q2 | $335K | Hold |
2,450
| – | – | 0.39% | 60 |
|
2020
Q1 | $264K | Hold |
2,450
| – | – | 0.26% | 77 |
|
2019
Q4 | $295K | Hold |
2,450
| – | – | 0.22% | 81 |
|
2019
Q3 | $240K | Hold |
2,450
| – | – | 0.16% | 86 |
|
2019
Q2 | $267K | Hold |
2,450
| – | – | 0.18% | 88 |
|
2019
Q1 | $274K | Hold |
2,450
| – | – | 0.19% | 89 |
|
2018
Q4 | $236K | Hold |
2,450
| – | – | 0.18% | 91 |
|
2018
Q3 | $299K | Hold |
2,450
| – | – | 0.19% | 87 |
|
2018
Q2 | $269K | Buy |
2,450
+200
| +9% | +$22K | 0.18% | 89 |
|
2018
Q1 | $240K | Hold |
2,250
| – | – | 0.16% | 92 |
|
2017
Q4 | $240K | Hold |
2,250
| – | – | 0.16% | 90 |
|
2017
Q3 | $250K | Hold |
2,250
| – | – | 0.17% | 88 |
|
2017
Q2 | $233K | Buy |
+2,250
| New | +$233K | 0.17% | 90 |
|